$3.71
0.02[0.54%]
At close: Apr 26
$3.71
0[0.00%]
After Hours: 4:20PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/12/2024 | MXCT | MaxCyte | FY | 2024 | — | — | — | $32.80M | $34.29M | $40.31M | Get Alert |
03/04/2024 | MXCT | MaxCyte | FY | 2023 | — | — | — | $29.60M | $29.80M | $39.77M | Get Alert |
03/04/2024 | MXCT | MaxCyte | FY | 2024 | — | — | — | $29.60M | $31.29M | $42.14M | Get Alert |
01/08/2024 | MXCT | MaxCyte | FY | 2023 | — | — | — | $41.10M | $41.30M | $36.72M | Get Alert |
01/08/2024 | MXCT | MaxCyte | Q4 | 2023 | — | — | — | $15.50M | $15.70M | $10.74M | Get Alert |
11/08/2023 | MXCT | MaxCyte | FY | 2023 | — | — | — | $28.00M | $30.00M | $40.07M | Get Alert |
10/04/2023 | MXCT | MaxCyte | FY | 2023 | — | — | — | $34.00M | $36.00M | $45.07M | Get Alert |
10/04/2023 | MXCT | MaxCyte | Q3 | 2023 | — | — | — | $7.80M | $8.00M | $11.35M | Get Alert |
05/10/2023 | MXCT | MaxCyte | FY | 2023 | — | — | — | $47.80M | $49.57M | $54.29M | Get Alert |
03/15/2023 | MXCT | MaxCyte | FY | 2023 | — | — | — | $53.56M | $55.77M | $57.88M | Get Alert |
03/06/2023 | MXCT | MaxCyte | FY | 2022 | — | — | — | $44.30M | $44.30M | $44.77M | Get Alert |
03/06/2023 | MXCT | MaxCyte | Q4 | 2022 | — | — | — | $12.40M | $12.40M | $12.90M | Get Alert |
04/12/2022 | MXCT | MaxCyte | Q1 | 2022 | — | — | — | $11.00M | — | $8.46M | Get Alert |
01/24/2022 | MXCT | MaxCyte | Q4 | 2021 | — | — | — | $10.00M | — | $9.29M | Get Alert |
01/24/2022 | MXCT | MaxCyte | FY | 2021 | — | — | — | $33.70M | — | $33.03M | Get Alert |
11/10/2021 | MXCT | MaxCyte | FY | 2021 | — | — | — | $33.00M | — | $29.87M | Get Alert |
09/13/2021 | MXCT | MaxCyte | FY | 2021 | — | — | — | $30.00M | $30.00M | — | Get Alert |
There have been no specific sales or earnings guidance reported for MaxCyte in recent months.
Browse guidance and forecast on all stocks.